Moneycontrol PRO
Upcoming Event:Join us for New HorAIzon from Oct 6-7, 2pm and be a part of exciting conversations on tech & innovation
you are here: HomeNewsIndia

COVID-19 Vaccine Tracker News: Over 1.7 lakh beneficiaries receive coronavirus vaccine in India on February 2

More than 41 lakh people have so far been vaccinated for COVID-19 in India. Of these, over 1.70 lakh people received the vaccine on February 2.

February 03, 2021 / 09:24 AM IST
Source: AP

Source: AP

A total of 41,20,741 beneficiaries have so far been vaccinated for COVID-19 through 76,516 sessions held till the evening of February 2, the 18th  day of the immunisation drive, according to a provisional report of the Union Health Ministry.

On February 2, 1,70,585 beneficiaries were vaccinated till 7.00 pm through 3,785 vaccination sessions, the ministry said. 106 cases of adverse event following immunisation (AEFI) were reported till 7 pm on Day 18 of the vaccination drive, it said.

Two states, Gujarat and West Bengal, initiated vaccination of frontline workers on the day. A total of 19,902 frontline workers were vaccinated till 7 pm on the day, as per the provisional report.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Prime Minister Narendra Modi launched the vaccination drive with healthcare workers at the frontline of India's COVID-19 battle getting their first jabs on January 16.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

India’s drug regulator has approved two vaccines - Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India (SII) - for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.

Here are all developments related to the COVID-19 vaccine in India:

> Punjab DGP Dinkar Gupta was the first one to receive the COVID-19 vaccine in the state police as the second phase of inoculation drive for frontline workers began on February 2. Chief Minister Amarinder Singh rolled out the second phase of the COVID-19 vaccination drive on the day.

> A total of 9,357 people were administered the vaccine in Delhi on the day. Seventeen cases of AEFI were reported during the day and around 51 percent of the targeted beneficiaries were inoculated, they said. Covishield was given to 8,131 beneficiaries at 150 centres of the Delhi government, while Covaxin jabs were administered to 1,226 healthcare workers at 33 centres in central government-run hospitals, officials said.

> Coronavirus vaccine jabs will to be given six days a week in Delhi from now on instead of the earlier four days, according to officials.

> The COVID-19 vaccine is being provided free of cost to states and union territories for vaccination of healthcare and frontline workers in the first phase of vaccination, Minister of State for Health Ashwini Choubey informed Rajya Sabha on the day. On whether any state has announced to supply the COVID-19 vaccine to the public free of cost including Kerala, Choubey said, "The government of India has not received any formal communication from states and UTs regarding announcement to supply the COVID-19 vaccine to the public free of cost, including Kerala."

> The second phase of the COVID-19 vaccine will be rolled out in Haryana on February 3 and frontline workers will get the jab during the drive. To ensure its smooth implementation of the drive, the registration of all such workers will be completed on the CoWIN portal by February 7.

Here is the state-wise vaccination:
StatesTotal Beneficiaries
Andhra Pradesh1,87,252
Arunachal Pradesh9,791
Himachal Pradesh39,570
Madhya Pradesh2,98,376
Tamil Nadu1,20,745
Uttar Pradesh4,63,793
West Bengal2,84,228

(With inputs from PTI)

Follow our full coverage on COVID-19 here.
Moneycontrol News
first published: Feb 3, 2021 09:24 am

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark